Federal contract award
75N94020P00379
TOTALSEQ SERVICES: 10X CHROMIUM SINGLE CELL RNA-SEQ WITH FEATURE BARCODING LIBRARY SEQUENCING QUOTE NO: SCGA20030401A SINGULOMICS CORPORATION:1286833 [20-006966]
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | NATIONAL INSTITUTES OF HEALTH NICHD |
| NAICS | 541714 — Research and Development in Biotechnology (except Nanobiotechnology) |
| PSC | 6640 — Laboratory Equipment and Supplies |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $193.8K |
| Current contract value | $193.8K |
| Potential contract value / ceiling | $193.8K |
| Start date | Jun 1, 2020 |
| Current end date | May 30, 2021 |
| Potential end date | May 30, 2021 |
| Latest award activity | May 20, 2020 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 2 of 2 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| May 20, 2020 | 0 | $193.8K | TOTALSEQ SERVICES: 10X CHROMIUM SINGLE CELL RNA-SEQ WITH FEATURE BARCODING LIBRARY SEQUENCING QUOTE NO: SCGA20030401A SINGULOMICS CORPORATION:1286833 [20-006966] |
| May 20, 2020 | P00001 | $0 | TOTALSEQ SERVICES: 10X CHROMIUM SINGLE CELL RNA-SEQ WITH FEATURE BARCODING LIBRARY SEQUENCING QUOTE NO: SCGA20030401A SINGULOMICS CORPORATION:1286833 [20-006966] |
Buyer contacts from matching notices
Matched on exact award/solicitation identifier and awarding agency. Source dates describe the notice, not current contact verification.
| Contact | Role | Published contact methods | Evidence | Source date |
|---|---|---|---|---|
| TINA ROBINSON | Contact | robinsti@mail.nih.gov | Source | May 13, 2020 |
Research next steps
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.